ArticleMethods in molecular biology (Clifton, N.J.)2025
The DNA Damage Response as an Auxiliary Indicator of Senescence in Cancer: A User-Friendly Toolkit of Markers and Detection Methods.
Article in Methods in molecular biology (Clifton, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Senescence is a cellular stress response causing a stable exit from the cell cycle. Limitation of cell proliferation is accompanied by a variety of characteristic changes, including cellular and nuclear morphological alterations, chromatin rearrangements, metabolic reprogramming, nuclear envelope rupture, and an immunomodulatory secretome, termed senescence-associated secreted phenotype (SASP). Senescence is a robust mechanism of tissue homeostasis, with crucial roles in eliminating dysfunctional and/or premalignant cells, and tissue repair. Activation of oncogenes triggers senescence, which in turn arrests DNA-damaged cells. This type of response, known as oncogene-induced senescence (OIS) is a powerful barrier to oncogenesis. However, in specific contexts, senescent cells support tumor progression, mainly via their secretome-mediated activities. The dynamic, context-dependent and ambivalent nature of senescence challenges the identification, characterization, and specific targeting of senescent cells for disease management. Importantly, senescence is highly intertwined with DNA damage response and repair (DDR/R) machinery that safeguards genome integrity. DNA damage events are frequently prevalent, while DDR/R signaling pathways are active during cellular senescence. In this regard, it can serve as an auxiliary indicator for senescent cells. In this chapter, we emphasize DDR/R as a shared hallmark of cancer and senescence. We provide a wieldy toolkit of experimental methods for monitoring DDR-related senescence markers, and we demonstrate the potential of using natural language processing to extract additional DDR/R biomarkers tailored to specific cancer types. Our methodologies can facilitate a comprehensive study of senescence in aging and cancer.
Indexed as
Identifiers
40082352What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.